These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 19808288)

  • 1. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
    Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
    Adabag AS; Maron BJ; Appelbaum E; Harrigan CJ; Buros JL; Gibson CM; Lesser JR; Hanna CA; Udelson JE; Manning WJ; Maron MS
    J Am Coll Cardiol; 2008 Apr; 51(14):1369-74. PubMed ID: 18387438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy.
    Satoh H; Matoh F; Shiraki K; Saitoh T; Odagiri K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2009 Jun; 15(5):419-27. PubMed ID: 19477402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Appelbaum E; Harrigan CJ; Salton C; Gibson CM; Udelson JE; O'Donnell C; Lesser JR; Manning WJ; Maron MS
    Am J Cardiol; 2010 Jul; 106(2):261-7. PubMed ID: 20599013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
    J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Pujadas S; Vidal-Perez R; Hidalgo A; Leta R; Carreras F; Barros A; Bayes-Genis A; Subirana MT; Pons-Llado G
    Eur J Radiol; 2010 Aug; 75(2):e88-91. PubMed ID: 20079992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction.
    Cheong BY; Muthupillai R; Wilson JM; Sung A; Huber S; Amin S; Elayda MA; Lee VV; Flamm SD
    Circulation; 2009 Nov; 120(21):2069-76. PubMed ID: 19901193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.
    Boonyasirinant T; Rajiah P; Setser RM; Lieber ML; Lever HM; Desai MY; Flamm SD
    J Am Coll Cardiol; 2009 Jul; 54(3):255-62. PubMed ID: 19589439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.
    Kitaoka H; Kubo T; Okawa M; Takenaka N; Baba Y; Yamasaki N; Matsumura Y; Furuno T; Doi YL
    J Cardiol; 2011 Nov; 58(3):261-5. PubMed ID: 21890325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.